Philippe Bonniaud

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Human Immunodeficiency Virus

Pulmonary Fibrosis

Cross Sectional

Coronavirus Disease

Top Venues

The European respiratory journal

International journal of environmental research and public health

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Julie Tanguy, Pierre-Marie Boutanquoi, Olivier Burgy, Lucile Dondaine, Guillaume Beltramo, Burhan Uyanik, Carmen Garrido, Philippe Bonniaud, Pierre-Simon Bellaye, Françoise Goirand
HSPB5 Inhibition by NCI-41356 Reduces Experimental Lung Fibrosis by Blocking TGF-β1 Signaling. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Mathieu Boulin, Amélie Cransac, Marc Maynadié, Fabienne Volot, Catherine Creuzot-Garcher, Jean-Christophe Eicher, Frédéric Chagué, Eléa Ksiazek, Guillaume Beltramo, Philippe Bonniaud, Thibault Moreau, Bernard Bonnotte, Edith Sales-Wuillemin, Agnès Soudry-Faure, Marianne Zeller, Yves Cottin
COVID-19 Lockdown in Patients with Chronic Diseases: A Cross-Sectional Study. International journal of environmental research and public health 19 (7) (2022)
Olivier Burgy, Sabrina Loriod, Guillaume Beltramo, Philippe Bonniaud
Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis. Cells 11 (7) (2022)
Olivier Burgy, Bruno Crestani, Philippe Bonniaud
Targeting the nasty nestin to shoot lung fibrosis. The European respiratory journal 59 (5) (2022)
Thomas Maitre, Jonathan Cottenet, Cendrine Godet, Adrien Roussot, Nafiz Abdoul Carime, Vichita Ok, Antoine Parrot, Philippe Bonniaud, Catherine Quantin, Jacques Cadranel
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis. The European respiratory journal 58 (2) (2021)